Results 41 to 50 of about 3,930 (204)

Changes in three tumor markers in patients with advanced lung adenocarcinoma after combination therapy with pemetrexed and platinum: Short-term treatment efficacy [PDF]

open access: yes, 2021
Purpose: To study changes in three tumor markers before and after combination treatment with pemetrexed and platinum, and evaluate the short-term therapeutic effectiveness of the treatment in advanced lung adenocarcinoma (ALA) subjects.
Chen, Xianguo   +4 more
core   +2 more sources

Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma

open access: yesNeoplasma, 2015
We investigated if the serum cytokeratin 19 fragment 21.1 (CYFRA21-1) level was elevated in nasopharyngeal carcinoma (NPC) and can function as a biomarker for detection and monitoring of NPC. Three hundred and one study subjects were divided into two groups: the NPC group (n=126) and healthy control group (n=175).
X M, Song   +5 more
openaire   +3 more sources

A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study

open access: yesLife, 2021
Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of
Narongchai Autsavapromporn   +7 more
doaj   +1 more source

Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients [PDF]

open access: yes, 2015
There is a clinical need for reliable biomarkers for lung cancer that permit early diagnosis of the disease and provide prediction of histological phenotype.
AG Serrano   +40 more
core   +1 more source

A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome [PDF]

open access: yes, 2016
Proteolytic cascades are deeply involved in critical stages of cancer progression. During the course of peptide-wise analysis of shotgun proteomic data sets representative of colon adenocarcinoma (AC) and ulcerative colitis (UC), we detected a cancer-
Dadlez, Michal   +7 more
core   +1 more source

CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis

open access: yesGenetics and Molecular Research, 2015
The proteolytic region of cytokeratin-19, referred to as CYFRA21-1, is a soluble molecule present in the serum and other body fluids, and is considered a tumor marker in several neoplastic diseases. To examine whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis ...
L I, Kuang   +4 more
openaire   +2 more sources

The application of CYFRA21-1 in cervical lesions screening in high-risk human papillomavirus infected women [PDF]

open access: yes, 2016
Objectives: To investigate the role of cytokeratin-19 fragment (CYFRA21-1) in cervical lesions screening in high-risk hu­man papillomavirus (HR-HPV) infected women. Material and methods: The study was a retrospective study.
Jia, Yang   +2 more
core   +2 more sources

ANGER IN CHILDREN: A MINIREVIEW [PDF]

open access: yes, 2017
Aggressive behavior is a peculiar characteristic of most animal species playing an important role in species preservation and two types have been identified: interspecific and intraspecific aggression.
D\u2019Oro, L.   +8 more
core   +1 more source

Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic [PDF]

open access: yes, 2015
YesContext: Urinary biomarkers are promising as simple alternatives to cystoscopy for the diagnosis of de novo and recurrent bladder cancer. Objective: To identify a highly sensitive and specific biomarker candidate set with potential clinical utility ...
De Paoli, M.   +7 more
core   +1 more source

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

open access: yesInternational Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.
What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy